Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

Source: Nasdaq GlobeNewswire / 12 Dec 2023 06:00:00   America/Chicago